NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth

STATE COLLEGE, Pa., Aug. 30, 2021 -- (Healthcare Sales & Marketing Network) -- NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $10+ million Series Pre-A financing round. The round ... Regenerative Medicine, Neurology, Venture Capital NeuExcell Therapeutics, gene therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news